Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.

Memorias do Instituto Oswaldo Cruz - 1 Nov 2017

Cayci Yeliz Tanriverdi, Bilgin Kemal, Coban Ahmet Yilmaz, Birinci Asuman, Durupınar Belma

Abstract excerpt

BACKGROUND: Mycobacterium tuberculosis (MTB) is one of the most significant causes of mortality and morbidity. Early diagnose is important especially in multiple drug resistant tuberculosis to avoid transmission. Traditional techniques requires at least one to three weeks for diagnosis of tuberculosis. Diagnostic delays with multiple drug resistant tuberculosis are associated with worse clinical outcomes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Tuberculosis, Pulmonary
Share to Antibiotics, Antitubercular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mycobacterium tuberculosis

Share to Reproducibility of Results

Share to Rifampin

Share to Sensitivity and Specificity

Share to Sputum

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 29091135
DOI: 10.1590/0074-02760170051
PMCID: PMC5661898

Genes

DST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.PMID 29091135Read ↗

Access the Diagnostic Accuracy of GeneXpert to Detect <em>Mycobacterium tuberculosis</em> and Rifampicin-Resistance Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis PatientsSemantic proximity Read ↗

Evaluation of the Analytical Performance of the Xpert MTB/RIF AssaySemantic proximity Read ↗

Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings.Semantic proximity Read ↗

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis.Semantic proximity Read ↗

Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.Semantic proximity Read ↗

Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013.Semantic proximity Read ↗

Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive OverviewSemantic proximity Read ↗

Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.Semantic proximity Read ↗

Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview.Semantic proximity Read ↗

[Performance of GeneXpert MTB / RIF® in the diagnosis of extrapulmonary tuberculosis in Dakar: 2010-2015].Semantic proximity Read ↗

Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.Semantic proximity Read ↗

Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.